AllNewsVideos'Novartis' - 194 News Result(s)Novartis Pharma Signs World's 1st Licensing Deal For Cancer DrugWorld News | Agence France-Presse | Thursday October 20, 2022 Pharmaceutical giant Novartis has signed a licensing agreement increasing access to a vital leukaemia treatment, a UN-backed public health organisation said Thursday, marking the first-ever such agreement for a cancer drug. www.ndtv.comHigh Court Restrains Generic Pharma Firms From Making, Selling Patent Drug Of NovartisIndia News | Press Trust of India | Tuesday November 2, 2021 The Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan and Sacubitril tablets, a combination to treat cardiovascular diseases, as it may amount to infringement of patent of pharma major www.ndtv.comNovartis India Sheds Over 6% Even After Net Profit Rises 43% In March QuarterBusiness | Edited by Nikita Prasad | Friday June 18, 2021 Novartis India Share Price Today: On Friday, Novartis India opened on the BSE at Rs 881, swinging to an intra day high of Rs 883.35 and an intra day low of Rs 797.35, so far www.ndtv.com/businessStocks To Watch: PowerGrid Corporation, Novartis India, Natco PharmaBusiness | Edited by Peter Noronha | Friday June 18, 2021 PowerGrid Corporation reported a 6 per cent rise in consolidated net profit to Rs 3,526.23 crore in the quarter ended March 2021 from Rs 3,313.47 crore in the same quarter last fiscal www.ndtv.com/businessGujarat Couple Raise Rs 16 Crore For 1 Injection To Save 5-Month-Old SonIndia News | Press Trust of India | Wednesday May 5, 2021 A couple from Gujarat has raised Rs 16 crore with the help of a crowdfunding platform to buy a gene therapy injection for the treatment of their 5-month-old son suffering from spinal muscular atrophy, a rare genetic disorder. www.ndtv.comSwiss Drugmaker Novartis To Help Make Pfizer-Biontech Coronavirus VaccineWorld News | Reuters | Friday January 29, 2021 Swiss drugmaker Novartis has signed an initial agreement to provide manufacturing capacity for Pfizer and Biontech's COVID-19 vaccine, a move aimed at helping boost production as supplies fall shy of demand. www.ndtv.comDr Reddy's Labs Gains On Launching Eye Allergy Drop In US MarketBusiness | Edited by Abhishek Vasudev | Thursday September 17, 2020 Olopatadine Hydrochloride Ophthalmic Solution USP is equivalent of Novartis's Pataday and is indicated for the temporary relief of itchy eyes . www.ndtv.com/businessSwiss Firm Novartis Stops Hydroxychloroquine Trial For COVID-19 TreatmentWorld News | Agence France-Presse | Saturday June 20, 2020 Swiss pharmaceuticals giant Novartis has decided to halt a clinical trial of hydroxychloroquine as a treatment for COVID-19, citing problems in recruiting enough patients for the study of the controversial drug. www.ndtv.comNovartis Sickle-Cell Drug Gets US ApprovalBusiness | Reuters | Saturday November 16, 2019 The drug will be priced between $84,852 and $113,136 per year for most patients, who will typically infuse themselves with between three and four vials each month, Novartis said. www.ndtv.com/businessJust Approved Gene Therapy Drug Is World's Most Expensive At $2.1 MillionWorld News | Christopher Rowland, The Washington Post | Saturday May 25, 2019 The Food and Drug Administration on Friday approved the most expensive drug in the world, a $2.1 million, one-time gene therapy for treatment of a rare disease that afflicts infants. www.ndtv.comGoogle Parent Alphabet's Verily Unit Halts Glucose-Detecting Contact Lens Project Reuters | Monday November 19, 2018 Verily, which was previously part of the tech firm's Google X research and development unit, had partnered with Novartis' eye-care division, Alcon, to develop the lens. www.gadgets360.comAurobindo Pharma Buys Parts Of Sandoz US From Novartis For $900 MillionBusiness | Thomson Reuters | Thursday September 6, 2018 Novartis AG said on Thursday it would sell the dermatology and generic US oral solids portfolios of Sandoz US to Aurobindo Pharma Ltd for $900 million, as the Swiss drug maker looks to focus on higher growth areas. The deal also includes about 300 products and additional development projects of Sandoz and an additional $100 million in performance... www.ndtv.com/businessSwiss Pharmaceutical Giant Novartis To Inject $100 Million Into New Treatments For MalariaWorld News | Agence France-Presse | Tuesday April 17, 2018 Swiss pharmaceutical giant Novartis on Tuesday announced $100 million of funding over the next five years for research into new treatments for malaria, a mosquito-borne disease with a devastating impact that killed 445,000 people in 2016. www.ndtv.comGSK Set To Buy Novartis Stake In Joint Venture For $13 Billion, Might Lose Horlicks BrandBusiness | NDTV Profit Team | Wednesday March 28, 2018 Completion of the buyout by GSK of Novartis 36.5% stake in the joint venture is currently expected to occur during the summer of 2018. www.ndtv.com/businessGSK Buys Novartis Stake In Consumer Healthcare Venture For $13 billionBusiness | Thomson Reuters | Tuesday March 27, 2018 The deal is set to complete in the second quarter subject to the necessary approvals. www.ndtv.com/businessMore News »'Novartis' - 16 Video Result(s)Drug Price Cap to Impact Glaxo, Sanofi, Novartis most: Prabhudas LilladherJul 15, 201410:28Novartis verdict fallout: Patents vs patients?Apr 6, 201350:44Launching anti-ageing skin care product: PiramalApr 4, 20138:05Novartis ruling shows India doesn't want innovation: Peter PittsApr 3, 20133:55The 9 O'clock News: The biggest stories (April 2, 2013)Apr 2, 201350:15Patent war: patients vs profit?Apr 2, 201335:39अब सस्ती मिलेगी कैंसर की दवाApr 2, 201344:47Money Mantra: Analysis Supreme Court’s verdict on NovartisApr 2, 201350:02Supreme Court backs generics in Novartis drug patent rulingApr 1, 20132:23सर्वोच्च न्यायालय ने नोवार्टिस की याचिका खारिज कीApr 1, 20132:09Supreme Court denies Novartis patent for cancer drugApr 1, 201320:01Advise investors to buy Ranbaxy in Pharma space: Sharmila JoshiApr 1, 201325:12Growth, social equity go hand in handNov 7, 201222:59More should have been done for farmers: Ranjit ShahaniJul 6, 20091:11Pharma majors keen on ShanthaApr 24, 20092:06More Videos »'Novartis' - 194 News Result(s)Novartis Pharma Signs World's 1st Licensing Deal For Cancer DrugWorld News | Agence France-Presse | Thursday October 20, 2022 Pharmaceutical giant Novartis has signed a licensing agreement increasing access to a vital leukaemia treatment, a UN-backed public health organisation said Thursday, marking the first-ever such agreement for a cancer drug. www.ndtv.comHigh Court Restrains Generic Pharma Firms From Making, Selling Patent Drug Of NovartisIndia News | Press Trust of India | Tuesday November 2, 2021 The Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan and Sacubitril tablets, a combination to treat cardiovascular diseases, as it may amount to infringement of patent of pharma major www.ndtv.comNovartis India Sheds Over 6% Even After Net Profit Rises 43% In March QuarterBusiness | Edited by Nikita Prasad | Friday June 18, 2021 Novartis India Share Price Today: On Friday, Novartis India opened on the BSE at Rs 881, swinging to an intra day high of Rs 883.35 and an intra day low of Rs 797.35, so far www.ndtv.com/businessStocks To Watch: PowerGrid Corporation, Novartis India, Natco PharmaBusiness | Edited by Peter Noronha | Friday June 18, 2021 PowerGrid Corporation reported a 6 per cent rise in consolidated net profit to Rs 3,526.23 crore in the quarter ended March 2021 from Rs 3,313.47 crore in the same quarter last fiscal www.ndtv.com/businessGujarat Couple Raise Rs 16 Crore For 1 Injection To Save 5-Month-Old SonIndia News | Press Trust of India | Wednesday May 5, 2021 A couple from Gujarat has raised Rs 16 crore with the help of a crowdfunding platform to buy a gene therapy injection for the treatment of their 5-month-old son suffering from spinal muscular atrophy, a rare genetic disorder. www.ndtv.comSwiss Drugmaker Novartis To Help Make Pfizer-Biontech Coronavirus VaccineWorld News | Reuters | Friday January 29, 2021 Swiss drugmaker Novartis has signed an initial agreement to provide manufacturing capacity for Pfizer and Biontech's COVID-19 vaccine, a move aimed at helping boost production as supplies fall shy of demand. www.ndtv.comDr Reddy's Labs Gains On Launching Eye Allergy Drop In US MarketBusiness | Edited by Abhishek Vasudev | Thursday September 17, 2020 Olopatadine Hydrochloride Ophthalmic Solution USP is equivalent of Novartis's Pataday and is indicated for the temporary relief of itchy eyes . www.ndtv.com/businessSwiss Firm Novartis Stops Hydroxychloroquine Trial For COVID-19 TreatmentWorld News | Agence France-Presse | Saturday June 20, 2020 Swiss pharmaceuticals giant Novartis has decided to halt a clinical trial of hydroxychloroquine as a treatment for COVID-19, citing problems in recruiting enough patients for the study of the controversial drug. www.ndtv.comNovartis Sickle-Cell Drug Gets US ApprovalBusiness | Reuters | Saturday November 16, 2019 The drug will be priced between $84,852 and $113,136 per year for most patients, who will typically infuse themselves with between three and four vials each month, Novartis said. www.ndtv.com/businessJust Approved Gene Therapy Drug Is World's Most Expensive At $2.1 MillionWorld News | Christopher Rowland, The Washington Post | Saturday May 25, 2019 The Food and Drug Administration on Friday approved the most expensive drug in the world, a $2.1 million, one-time gene therapy for treatment of a rare disease that afflicts infants. www.ndtv.comGoogle Parent Alphabet's Verily Unit Halts Glucose-Detecting Contact Lens Project Reuters | Monday November 19, 2018 Verily, which was previously part of the tech firm's Google X research and development unit, had partnered with Novartis' eye-care division, Alcon, to develop the lens. www.gadgets360.comAurobindo Pharma Buys Parts Of Sandoz US From Novartis For $900 MillionBusiness | Thomson Reuters | Thursday September 6, 2018 Novartis AG said on Thursday it would sell the dermatology and generic US oral solids portfolios of Sandoz US to Aurobindo Pharma Ltd for $900 million, as the Swiss drug maker looks to focus on higher growth areas. The deal also includes about 300 products and additional development projects of Sandoz and an additional $100 million in performance... www.ndtv.com/businessSwiss Pharmaceutical Giant Novartis To Inject $100 Million Into New Treatments For MalariaWorld News | Agence France-Presse | Tuesday April 17, 2018 Swiss pharmaceutical giant Novartis on Tuesday announced $100 million of funding over the next five years for research into new treatments for malaria, a mosquito-borne disease with a devastating impact that killed 445,000 people in 2016. www.ndtv.comGSK Set To Buy Novartis Stake In Joint Venture For $13 Billion, Might Lose Horlicks BrandBusiness | NDTV Profit Team | Wednesday March 28, 2018 Completion of the buyout by GSK of Novartis 36.5% stake in the joint venture is currently expected to occur during the summer of 2018. www.ndtv.com/businessGSK Buys Novartis Stake In Consumer Healthcare Venture For $13 billionBusiness | Thomson Reuters | Tuesday March 27, 2018 The deal is set to complete in the second quarter subject to the necessary approvals. www.ndtv.com/businessMore News »'Novartis' - 16 Video Result(s)Drug Price Cap to Impact Glaxo, Sanofi, Novartis most: Prabhudas LilladherJul 15, 201410:28Novartis verdict fallout: Patents vs patients?Apr 6, 201350:44Launching anti-ageing skin care product: PiramalApr 4, 20138:05Novartis ruling shows India doesn't want innovation: Peter PittsApr 3, 20133:55The 9 O'clock News: The biggest stories (April 2, 2013)Apr 2, 201350:15Patent war: patients vs profit?Apr 2, 201335:39अब सस्ती मिलेगी कैंसर की दवाApr 2, 201344:47Money Mantra: Analysis Supreme Court’s verdict on NovartisApr 2, 201350:02Supreme Court backs generics in Novartis drug patent rulingApr 1, 20132:23सर्वोच्च न्यायालय ने नोवार्टिस की याचिका खारिज कीApr 1, 20132:09Supreme Court denies Novartis patent for cancer drugApr 1, 201320:01Advise investors to buy Ranbaxy in Pharma space: Sharmila JoshiApr 1, 201325:12Growth, social equity go hand in handNov 7, 201222:59More should have been done for farmers: Ranjit ShahaniJul 6, 20091:11Pharma majors keen on ShanthaApr 24, 20092:06More Videos »Your search did not match any documentsA few suggestionsMake sure all words are spelled correctlyTry different keywordsTry more general keywordsCheck the NDTV Archives:https://archives.ndtv.com